Prevention of islet allograft rejection in diabetic mice by targeting Janus Kinase 3 with 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (JANEX-1) |
| |
| Authors: | Cetkovic-Cvrlje Marina Dragt Angela L Uckun Fatih M |
| |
| Affiliation: | Department of Immunology, Parker Hughes Institute and Parker Hughes Cancer Center, St. Paul, MN, USA. |
| |
| Abstract: | Janus kinase (JAK) 3-deficient mice were not able to reject allogeneic islet allografts. The JAK3 inhibitor 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (CAS 202475-60-3, JANEX-1, WHI-P131) prevented the rejection of islet allografts in mice with a normal JAK3 expression status. The combination of JANEX-1 and cyclosporin A (CAS 59865-13-3) was more effective than either agent alone. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
